Personalizing the Management of Men with Intermediate-risk Prostate Cancer

被引：6
|
作者：
D'Amico, Anthony V. [1 ,2 ]
机构：
[1] Brigham & Womens Hosp, Dept Radiat Oncol, Boston, MA 02115 USA
[2] Dana Farber Canc Inst, Boston, MA 02115 USA
来源：
EUROPEAN UROLOGY | 2013年 / 64卷 / 06期
关键词：
GLEASON SCORE; DISEASE; MORTALITY; BIOPSIES;
D O I：
10.1016/j.eururo.2013.03.038
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：903 / 904
页数：2
相关论文
共 50 条
  • [41] Survival outcomes for young men with localized intermediate-risk prostate cancer: An analysis of the NCDB.
    Boyd, Graham
    Qureshi, Muhammad M.
    Gignac, Gretchen
    Hirsch, Ariel
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [42] African American men and hereditary/familial prostate cancer: Intermediate-risk populations for chemoprevention trials
    Powell, IJ
    Meyskens, FL
    [J]. UROLOGY, 2001, 57 (4A) : 178 - 181
  • [43] Importance of prostate volume in the stratification of patients with intermediate-risk prostate cancer
    Moschini, Marco
    Gandaglia, Giorgio
    Suardi, Nazareno
    Fossati, Nicola
    Cucchiara, Vito
    Damiano, Rocco
    Cantiello, Francesco
    Shariat, Shahrokh F.
    Montorsi, Francesco
    Briganti, Alberto
    [J]. INTERNATIONAL JOURNAL OF UROLOGY, 2015, 22 (06) : 555 - 561
  • [44] PREDICT Prostate, a useful tool in men with low- and intermediate-risk prostate cancer who are hesitant between conservative management and active treatment
    Gaëtan Devos
    Steven Joniau
    [J]. BMC Medicine, 18
  • [45] PREDICT Prostate, a useful tool in men with low- and intermediate-risk prostate cancer who are hesitant between conservative management and active treatment
    Devos, Gaetan
    Joniau, Steven
    [J]. BMC MEDICINE, 2020, 18 (01)
  • [46] INTERMEDIATE-RISK PROSTATE CANCER, ANDROGEN DEPRIVATION THERAPY AND THE RISK OF DEATH
    Pickles, Tom
    Tyldesley, Scott
    Keyes, Mira
    Morris, W. James
    [J]. RADIOTHERAPY AND ONCOLOGY, 2016, 120 : S27 - S27
  • [47] Brachytherapy for Intermediate-Risk Prostate Cancer, Androgen Deprivation, and the Risk of Death
    Pickles, Tom
    Tyldesley, Scott
    Hamm, Jeremy
    Virani, Sean A.
    Morris, W. James
    Keyes, Mira
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2018, 100 (01): : 45 - 52
  • [48] No significant difference in intermediate key outcomes in men with low- and intermediate-risk prostate cancer managed by active surveillance
    Cyll, Karolina
    Loffeler, Sven
    Carlsen, Birgitte
    Skogstad, Karin
    Plathan, May Lisbeth
    Landquist, Martin
    Haug, Erik Skaaheim
    [J]. SCIENTIFIC REPORTS, 2022, 12 (01)
  • [49] No significant difference in intermediate key outcomes in men with low- and intermediate-risk prostate cancer managed by active surveillance
    Karolina Cyll
    Sven Löffeler
    Birgitte Carlsen
    Karin Skogstad
    May Lisbeth Plathan
    Martin Landquist
    Erik Skaaheim Haug
    [J]. Scientific Reports, 12
  • [50] Active surveillance for intermediate-risk prostate cancer: yes, but for whom?
    Overland, Maya R.
    Washington, Samuel L., III
    Carroll, Peter R.
    Cooperberg, Matthew R.
    Herlemann, Annika
    [J]. CURRENT OPINION IN UROLOGY, 2019, 29 (06) : 605 - 611
12345